AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
15/12/2025 – AB Science today announced the publication of a new AB8939 article on the preprint platform bioRxiv